z-logo
open-access-imgOpen Access
Postjunctional α-Adrenoceptors and the Regulation of Arteriolar Tone in Humans
Author(s) -
van Brummelen P,
Jie Kang,
Timmermans Pb,
van Zwieten Pa
Publication year - 1985
Publication title -
journal of cardiovascular pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.762
H-Index - 100
eISSN - 1533-4023
pISSN - 0160-2446
DOI - 10.1097/00005344-198500076-00025
Subject(s) - methoxamine , yohimbine , doxazosin , vasoconstriction , clonidine , medicine , endocrinology , adrenergic , rauwolscine , antagonist , blood pressure , agonist , receptor
The highly selective alpha-adrenoceptor agonists methoxamine (alpha 1) and azepexole (alpha 2), the less selective alpha-adrenoceptor agonists clonidine (alpha 2 greater than alpha 1) and guanfacine (alpha 2 greater than alpha 1), and the highly selective antagonists doxazosin (alpha 1) and yohimbine (alpha 2) were used to study post-junctional alpha-adrenoceptor subtypes in human blood vessels. Studies were done in healthy volunteers. All drugs were given intraarterially, and changes in forearm blood flow were measured by plethysmography. All agonists produced a significant and dose-dependent vasoconstriction. The effect of azepexole was abolished by yohimbine but hardly influenced by doxazosin. The reverse was found for methoxamine. The clonidine and guanfacine-induced vasoconstriction was partly prevented by both antagonists. Single infusions of doxazosin and yohimbine gave significant vasodilation. It is concluded that post-junctional alpha 1-and alpha 2-adrenoceptors are present in human blood vessels and contribute to basal vascular tone. In a second study, it was shown that both alpha-adrenoceptor subtypes are involved in the vasoconstrictor effect of exogenous adrenaline and noradrenaline. No preference was found of either catecholamine for the postjunctional alpha 1-and alpha 2-adrenoceptor.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here